Table 3.
Outcomes | Placebo | Ciprofloxacin | Total | OR | 95% CI | P-value | |||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
n | % | n | % | n | % | ||||
Total patients | 52 | 47.3 | 58 | 52.7 | 110 | 100 | |||
Induction outcome | |||||||||
Complete remission | 39 | 75.0 | 40 | 69.0 | 79 | 71.8 | |||
Induction failures | 13 | 25.0 | 18 | 31.0 | 31 | 28.2 | 1.35a | 0.58–3.12 | 0.48# |
Death | 3 | 5.8 | 11 | 18.9 | 14 | 12.8 | 3.57a | 0.92–13.80 | 0.05# |
Abandonment | 7 | 13.5 | 3 | 5.2 | 10 | 9.0 | 0.42a | 0.10–1.73 | 0.32## |
Resistant disease | 3 | 5.8 | 4 | 6.9 | 7 | 6.4 | 1.3a | 0.27–6.19 | 1.00## |
Fever > 38.5°C | |||||||||
Never | 35 | 67.3 | 29 | 50.0 | 64 | 58.2 | |||
Ever | 17 | 32.7 | 29 | 50.0 | 46 | 41.8 | 2.06b | 0.95–4.47 | 0.07# |
Clinical sepsis | |||||||||
Never | 32 | 61.5 | 29 | 50.0 | 61 | 55.5 | |||
Ever | 20 | 38.5 | 29 | 50.0 | 49 | 44.5 | 1.60b | 0.75–3.42 | 0.22# |
Notes:
ORs for any induction failure and specific induction failures (CR is taken as the reference outcome category);
ORs for event of fever and clinical sepsis (Never is taken as the reference outcome category);
Chi-square test;
Fisher’s exact test.
Abbreviations: OR, odds ratio (ciprofloxacin group relative to placebo group); CI, confidence interval.